In this work, we designed and evaluated a convolutional neural network for prostate cancer diagnosis using volumetric T2-weighted MRI. Our key contribution is a 3D implementation of a residual network (ResNet), optimised to perform a classification between patients with prostate cancer and patients with benign conditions. On this task, cross-validation on a dataset consisting of 240 patients, produced a mean area under the receiver operating characteristic curve of 0.78, which was on par with an experienced radiologist.
This abstract and the presentation materials are available to members only; a login is required.